Pilot Digital Follow-up of Lung Cancer

Lung Cancer Clinical Trial

Official title: Pilot Study - Measurement of Cost, Outcome and Patient Experience of a Digital Weekly Follow up of Lung Cancer Patients

Status Completed

Clinical Trial Summary

In the pilot study, 30 patients with metastatic lung cancer (stage IV) will be recruited at the start of their stage IV treatment from February 2019. The study period per patient will last six months, from the start of the stage IV treatment. Patients are eligible if they are diagnosed with stage IV lung cancer, speak sufficient Dutch, and are willing to participate. Patients are randomly assigned to two arms by simple randomization. In the intervention arm, 15 patients will receive a weekly questionnaire. Alerts will be sent to the multidisciplinary care team, who will undertake follow-up actions. In the control arm, 15 patients will receive the standard care pathway without weekly questionnaire and without automatic alerts to the care team. The standard care pathways and the care team are the same in both groups. In this pilot study, the weekly follow-up will be evaluated by a validation questionnaire, semi-structured interviews with patients (n=5) and the care team (n=5), and workload registration of the care team during a six-month period for all included patients in the pilot.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Lung Cancer
• Lung Neoplasms

• NCT number: NCT04712149
• Study type: Interventional
• Source: Hasselt University
• Status: Completed
• Phase: N/A
• Start date: February 1, 2019
• Completion date: July 31, 2020